Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Revium Rx (RVRC) Change in Account Payables (2025 - 2026)

Updated

Revium Rx's Change in Account Payables came in at $359,000 for FY2025, compared with -$101,000 in FY2024.

Analysis

Revium Rx (RVRC) Change in Account Payables (2025 - 2026) Analysis & Trends

  • Per Business Quant, earlier years put Change in Account Payables at -$101,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Revium Rx 86.84 Mn 75.21 Mn - 389,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 389,000.00
Mar 31, 2026 68,000.00
Jun 30, 2025 64,000.00
Mar 31, 2025 -17,000.00
API Access

Revium Rx Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=RVRC&period=max&api_key=YOUR_API_KEY